Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

UCB Pharma AB (Sweden)

Closing information (x1000 NOK)

Closing information 2023/12 2022/12 2021/12
Turnover 236,492 Less Arrow 200,010 Less Arrow 194,793
Financial expenses 714 Less Arrow 465 Less Arrow 143
Earnings before taxes 12,351 Less Arrow 9,619 Less Arrow 9,587
EBITDA 12,344 Less Arrow 9,925 Less Arrow 9,683
Total assets 170,255 Less Arrow 124,992 Less Arrow 112,394
Current assets 170,255 Less Arrow 124,992 Less Arrow 112,394
Current liabilities 105,988 Less Arrow 66,747 Less Arrow 52,397
Equity capital 64,267 Less Arrow 58,245 More Arrow 59,998
- share capital 101 Less Arrow 95 More Arrow 98
Employees (average) 35 Less Arrow 30 More Arrow 31

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 37.7% More Arrow 46.6% More Arrow 53.4%
Turnover per employee 6,757 Less Arrow 6,667 Less Arrow 6,284
Profit as a percentage of turnover 5.2% Less Arrow 4.8% More Arrow 4.9%
Return on assets (ROA) 7.7% More Arrow 8.1% More Arrow 8.7%
Current ratio 160.6% More Arrow 187.3% More Arrow 214.5%
Return on equity (ROE) 19.2% Less Arrow 16.5% Less Arrow 16.0%
Change turnover 22,290 Less Arrow 11,072 Less Arrow 9,605
Change turnover % 10% Less Arrow 6% Less Arrow 5%
Chg. No. of employees 5 Less Arrow -1 More Arrow 5
Chg. No. of employees % 17% Less Arrow -3% More Arrow 19%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.